Cargando…
Resistance of infection by Plasmodium vivax to chloroquine in Bolivia
BACKGROUND: Chloroquine (CQ) over three days plus primaquine (PQ) for seven days is the treatment of choice of infections by Plasmodium vivax in Bolivia, where 95% of the cases of malaria are attributed to this species. The aim of this study was to evaluate the therapeutic efficacy of CQ in this set...
Autores principales: | Añez, Arletta, Moscoso, Manuel, Laguna, Ángel, Garnica, Cecilia, Melgar, Viviana, Cuba, Mauren, Gutierrez, Sonia, Ascaso, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488061/ https://www.ncbi.nlm.nih.gov/pubmed/26126708 http://dx.doi.org/10.1186/s12936-015-0774-4 |
Ejemplares similares
-
Evaluation of the paediatric dose of chloroquine in the treatment of Plasmodium vivax malaria
por: Añez, Arletta, et al.
Publicado: (2016) -
Plasmodium vivax Malaria during Pregnancy, Bolivia
por: Brutus, Laurent, et al.
Publicado: (2013) -
Chloroquine-Resistant Plasmodium
vivax, Brazilian Amazon
por: Filho, Franklin Simoes de Santana, et al.
Publicado: (2007) -
Plasmodium vivax trophozoites insensitive to chloroquine
por: Sharrock, Wesley W, et al.
Publicado: (2008) -
Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia
por: Mekonnen, Seleshi Kebede, et al.
Publicado: (2014)